Search

You searched for "simulation"

1827 results found

Intravitreal bevacizumab vs. ranibizumab in the treatment of macular oedema due to BRVO

1 June 2016 | | Paediatric Ophthalmology / Strabismus | Macula, Retina
This is a randomised, prospective, non-inferiority trial of 75 patients with macular oedema due to a branch retinal vein occlusion (BRVO) who received intravitreal injections of ranibizumab or bevacizumab after 1:1 block randomisation. This study is to measure the difference...

Injection frequency and anatomic outcomes following conversion to Aflibercept in neovascular AMD patients

1 December 2014 | | Retina / Uvea / Vitreous | Degeneration, Macula, Treatment Medical
This is a retrospective study of patients with neovascular age-related macular degeneration (AMD) treated with intravitreal Lucentis and / or Avastin who were switched to aflibercept (Eylea). This study was carried out by the Casey Eye Institute retinal clinics, between...

Ophthalmic Drugs Conference 2020

23 November 2020 -24 November 2020
SMi proudly presents the 4th Annual Ophthalmic Drugs Conference taking place on 23-24 November 2020, in London.

New study maps priorities for UK eyecare research

4 June 2024 | glaucoma, AMD, dry, wet, new study, research, updates, UK, eyecare
Glaucoma, age-related macular degeneration, childhood vision loss, and short-sightedness are highlighted as target study areas.

Quality matters in the management of serious eye disorders

1 June 2019 | | AMD, Cataract and Refractive, Cornea / External Eye Disease, Emergency Ophthalmology, Genetics, Glaucoma, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Ophthalmology, Optometry, Orbit, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous
The author discusses the first quality standard for serious eye disorders from NICE and takes a look at new care models for enhanced service delivery. Patient backlogs pose risks to patient safety, with research showing that people are losing sight...

What's trending Apr/May 2020

1 April 2020 | | Ophthalmology, Optometry, Retina / Uvea / Vitreous, Cataract and Refractive
#punch #shark Nick Minogue, a 60-year-old New Zealander, was surfing off Pauanui Beach when he was attacked by a Great White Shark. Luckily, he recalled advice that sharks are vulnerable if hit in the eyes or the nose. His first...

Money never sleeps

5 April 2022 | | Ophthalmology, Retina / Uvea / Vitreous
“I want you to deal with your problems by becoming rich” As declared by Jordan Belfort in a motivational speech to his staff in the film Wolf of Wall Street (2013). Unfortunately, medicine as a career does not lead to...

How to diagnose and treat Acanthamoeba keratitis

1 February 2019 | | Cornea / External Eye Disease, Ophthalmology
Corneal ulceration caused by Acanthamoeba is on the rise, and recent publications indicate an outbreak in the UK over the last few years [1]. Since Acanthamoeba keratitis often presents with atypical features, diagnosis from slit-lamp examination alone can often be...

Blind Veterans UK calls on eye health professionals to direct blind and vision impaired veterans to vital support

1 December 2015 | AMD, Cornea / External Eye Disease, Cataract and Refractive, Emergency Ophthalmology, Genetics, Glaucoma, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Ophthalmology, Optometry, Orbit, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous
A national charity is asking ophthalmologists and eye health professionals to help them reach out to the tens of thousands of blind and vision impaired ex-service men and women who are currently missing out on vital support to help them...

Discussing treatment modalities for bilateral wet AMD

1 December 2014 | | Retina / Uvea / Vitreous
A 65-year-old lady with bilateral wet AMD and vision of 6/24 comes with an internet search about current therapies. How do you explain the various treatment modalities available? There are two NICE approved treatments for wet age-related macular degeneration (AMD)....

Pituitary tumours: why are they so often missed?

1 August 2017 | | Neuro-Ophthalmology
Part 2: Clinical varieties, anatomical considerations and case report (see also Part 1 and Part 3) For ophthalmologists there are four types of pituitary tumour to be considered, three of which are named according to the hormone secreted, along with...

The results of the last survey Feb24

2 February 2024 | | Retina / Uvea / Vitreous
Thank you to all those who participated in this edition’s survey and for those of you who attended my recent Medico-legal Seminar at the Royal College of Ophthalmologists. It was a fascinating and educational day, made a success by the...